safety data sheet roferon-a pfs 3 m iu/0.5 ml · safety data sheet roferon-a pfs 3 m iu/0.5 ml ......

ROFERON-A PFS 3 M IU/0.5 mlSafety Data Sheet

SECTION 1: Identification of the substance/mixture and of thecompany/undertaking

1.1. Product identifier

Product name ROFERON-A PFS 3 M IU/0.5 ml

Product code SAP-10131273

1.2. Relevant identified uses of the substance or mixture and uses advised against

Use - pharmaceutical active substance *1*1

1.3. Details of the supplier of the safety data sheet

Enquiries:Roche Products Pty LimitedLevel 8, 30-34 Hickson RoadMillers Point NSW 2000Australia

Phone 0061-2-9454-9624Fax 0061-2-9971-7401E-Mail [email protected]

Local representation:Company information

1.4. Emergency telephone number

Phone 0061-2-9454-9624Emergency telephone number

*1 Interferon alfa-2areferring to:

SECTION 2: Hazards identification

2.1. / 2.2. Classification of the substance or mixture / Label elements

GHS Classification no classification and labelling according to GHS

Australian Remark - Poisons Schedule - Schedule 4 *1

- Not listed on the Australian Inventory of Chemical Substances(AICS) *1

- Listed on the Australian Inventory of Chemical Substances (AICS) *2




Page: 1/7Replacing edition of: 17.7.15Date: 3.11.17/LS (SEISMO)

ROFERON-A PFS 3 M IU/0.5 ml

2.3. Other hazards

Note - no information available

*1*2*3*4*5

Interferon alfa-2aSodium chlorideAmmonium acetateBenzyl alcoholPolysorbate 80

referring to: referring to: referring to: referring to: referring to:

SECTION 3: Composition/information on ingredients

Characterization Interferon alfa-2a with other inactive ingredients

Synonyms - ROFERON-A Prefilled Syringes 3 M IU/0.5 ml

Interferon alfa-2a 76543-88-9

6000000 I.U./ml

Ingredient Concentration GHS-Classification(pure ingredient)

Sodium chloride 7647-14-5

7.21 mg/ml

Ammonium acetate 631-61-8

0.77 mg/ml

Benzyl alcohol 100-51-6

10.0 mg/ml - Acute toxicity (Category 4), H312 - Acute toxicity (Category 4), H332 - Acute toxicity (Category 4), H302

Polysorbate 80 9005-65-6

0.2 mg/ml

water solution suitable for injection > 98 %

For the full text of the ’Hazard statements’ mentioned in this Section, see Section 16.

SECTION 4: First aid measures

4.1. Description of first aid measures

Eye contact - rinse immediately with tap water for at least 20 minutes - openeyelids forcibly

Skin contact - remove immediately contaminated clothes, wash affected skinwith water and soap - do not use any solvents

Inhalation - remove the casualty to fresh air and keep him/her calm- in the event of symptoms get medical treatment



4.2. Most important symptoms and effects, both acute and delayed


4.3. Indication of any immediate medical attention and special treatment needed

Note to physician - treat symptomatically

SECTION 5: Firefighting measures

5.1. Extinguishing media

Suitable extinguishing media - adapt extinguishing media to surrounding fire conditions

5.2. Special hazards arising from the substance or mixture

Specific hazards - no particular hazards known

5.3. Advice for firefighters

Protection of fire-fighters - precipitate gases/vapours/mists with water spray

SECTION 6: Accidental release measures

6.1. Personal precautions, protective equipment and emergency procedures

Personal precautions - no special precautions required

6.2. Environmental precautions

Environmental protection - no special environmental precautions required

6.3. Methods and material for containment and cleaning up

Methods for cleaning up - mop or flush the contaminated area with water

SECTION 7: Handling and storage

7.1. Precautions for safe handling

Suitable materials - glass

7.2. Conditions for safe storage, including any incompatibilities

Storage conditions - 2 - 8 °C- do not freeze



Validity - 24 months, 2 to 8 °C, after opening the content should be usedwithin a short period, see expiry date on the label

Packaging materials - keep it in the outer carton in order to protect from light- prefilled syringes

SECTION 8: Exposure controls/personal protection

8.1. Control parameters

Threshold value (Roche) air - IOEL (Internal Occupational Exposure Limit): 0.02 µg/m3 *1

8.2. Exposure controls

Respiratory protection - respiratory protection not necessary during normal operations

Hand protection - protective gloves (eg made of neoprene, nitrile or butyl rubber)

Eye protection - safety glasses


SECTION 9: Physical and chemical properties

9.1. Information on basic physical and chemical properties

Colour colourless

Form sterile liquid

pH value 4.8 to 5.2

9.2. Other information


SECTION 10: Stability and reactivity

10.1. Reactivity


10.2. Chemical stability

Stability - does not contain any antimicrobial preservative; therefore, caremust be taken to ensure the sterility of the prepared solution



10.3. Possibility of hazardous reactions


10.4. Conditions to avoid

Conditions to avoid - light- warming

10.5. Incompatible materials


10.6. Hazardous decomposition products


SECTION 11: Toxicological information

11.1. Information on toxicological effects

Acute toxicity LD0 250’000’000 I.U./kg (i.v., several species) *1-LD0 500’000’000 I.U./kg (i.m., several species) *1-LD0 800’000’000 I.U./kg (oral, several species) *1-

Local effects - eye: non-irritant (rabbit) *1

- skin: slightly irritant (rabbit) *1

Sensitization - no information available

Mutagenicity not mutagenic (various in vivo and in vitro test systems) *1-

Carcinogenicity no information available-

Reproductive toxicity - not teratogenic *1

STOT-single exposure - no information available

STOT-repeated exposure - no information available

Aspiration hazard - no information available

Note - Interferons are produced by cells as a reaction to viral infections.They are active against viruses, inhibit the growth of certain cellsand influence the immune systeme, sometimes inhibiting it,sometimes stimulating it. *1

- elimination half life: 5 hours; inactivation through renal filtrationand reabsorption processes *1

- at therapeutic doses, interferon alfa-2a commonly causesinfluenzalike symptoms such as fever, headache, myalgia etc. *1

- pre-existing auto-immune diseases may be influenced in aninpredictable manner, either positively or negatively *1



- about one fourth of those treated develop antibodies againstinterferon alfa-2a, however, these antibodies do not cause anysymptoms *1


SECTION 12: Ecological information

12.1. Toxicity

Ecotoxicity barely toxic for planktonic crustaceans (Daphnia magna)EC50 (48 h) > 100 mg/l (nominal concentration)NOEC (48 h) 100 mg/l (nominal concentration)(OECD No. 202) *1

-

barely toxic for algae (Desmodesmus (=Scenedesmus)subspicatus)ErC50 (72 h) > 100 mg/l (nominal concentration)EbC50 (72 h) < 100 mg/l (nominal concentration)NOEC (72 h) < 100 mg/l (nominal concentration)(OECD No. 201) *1

-

12.2. Persistence and degradability

Ready biodegradability - proteins are generally well biodegradable *1

- readily biodegradable100 % BOD/ThOD, 28 d(Manometric Respirometry Test, OECD No. 301 F) *6

12.3. Bioaccumulative potential


12.4. Mobility in soil


12.5. Results of PBT and vPvB assessment


12.6. Other adverse effects


*1*6

Interferon alfa-2aInterferon alfa-2a Solution

referring to: referring to:



SECTION 13: Disposal considerations

13.1. Waste treatment methods

Waste from residues - observe local/national regulations regarding waste disposal

SECTION 14: Transport information

Australian Remark - ADG Code: This product is not classified as a dangerous good.No special transport conditions are necessary unless required byother regulations.

SECTION 15: Regulatory information

15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture

Water hazard class (Germany) 1: weakly hazardous for water (according to directive AwSV of18.04.2017)

SECTION 16: Other information

Full text of H-Statements referred to under section 3H302 Harmful if swallowed.H312 Harmful in contact with skin.H332 Harmful if inhaled.

Note - 1 mg protein is equivalent to 270 m.I.U. *1

- Please note this Safety Data Sheet for the bulk product does notapply for the finished, packaged medicinal product intended forthe final user.

Edition documentation - changes from previous version in sections 3, 15


The information in this safety data sheet is based on current scientific knowledge. It should not betaken as expressing or implying any warranty concerning product characteristics.


ROFERON-A PFS 4.5 M IU/0.5 mlSafety Data Sheet



Product name ROFERON-A PFS 4.5 M IU/0.5 ml





















ROFERON-A PFS 4.5 M IU/0.5 ml

2.3. Other hazards


*1*2*3*4*5





Synonyms - ROFERON-A Prefilled Syringes 4.5 M IU/0.5 ml


9000000 I.U./ml



7.21 mg/ml


0.77 mg/ml




0.2 mg/ml






















Colour colourless

Form sterile liquid

pH value 4.8 to 5.2




10.1. Reactivity









12.1. Toxicity


-


-












*1*6












Water hazard class (Germany) 1: weakly hazardous for water (own classification according todirective VwVwS of 17.05.1999)










2.3. Other hazards


*1*2*3*4*5







12000000 I.U./ml



7.21 mg/ml


0.77 mg/ml




0.2 mg/ml






















Colour colourless

Form sterile liquid

pH value 4.8 to 5.2




10.1. Reactivity









12.1. Toxicity


-


-












*1*6





2.3. Other hazards


*1*2*3*4*5







18000000 I.U./ml



7.21 mg/ml


0.77 mg/ml




0.2 mg/ml






















Colour colourless

Form sterile liquid

pH value 4.8 to 5.2




10.1. Reactivity









12.1. Toxicity


-


-












*1*6




safety data sheet roferon-a pfs 3 m iu/0.5 ml · safety data sheet roferon-a pfs 3 m iu/0.5 ml ......

Documents